Ibnsina Pharma posts growth in 2021 profits
Updated 3/20/2022 11:01:27 AM
ArabFinance: Ibnsina Pharma (ISPH) reported an increase in its profits for the full year ended December 31st 2021, according to the company’s financial statements filed to the Egyptian Exchange (EGX).
The company’s consolidated net profit attributable to the holding company stood at EGP 314.72 million in 2021, up from EGP 224.66 million in 2020.
Consolidated net revenue amounted to EGP 21.73 billion last year, up from EGP 18.67 billion in 2020.
Meanwhile, the company’s standalone net profit after tax grew to EGP 315.65 million in 2021 from EGP 224.78 million in 2020.
Ibnsina is an Egypt-based pharmaceutical distribution company, with a diversified portfolio of pharmaceutical products from over 350 Egyptian and multinational companies to more than 35,000 customers including pharmacies, hospitals, retail outlets, and wholesalers.
